Albert David Limited
BSE: ALBERTDA
Prev Close
1072.6
Open Price
1086
Volume
5,565
Today Low / High
1066.1 / 1130
52 WK Low / High
255 / 1130
Range
1,031 - 1,139
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1084.85, reflecting a change of 12.25 (1.1421%). The expected target range on the BSE is 1,031 - 1,139. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
No data available
Albert David Limited Graph
Albert David Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Albert David Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,084.85, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,084.85 | 1,095.70 | 986.13 - 1,205.27 |
| 1,106.55 | 885.24 - 1,327.86 | ||
| 1,117.40 | 782.18 - 1,452.61 | ||
| Bearish Scenario | 1,084.85 | 1,074.00 | 966.60 - 1,181.40 |
| 1,063.15 | 850.52 - 1,275.78 | ||
| 1,052.30 | 736.61 - 1,368.00 |
Overview of Albert David Limited
ISIN
INE155C01010
Industry
Medical - Pharmaceuticals
Vol.Avg
2,888
Market Cap
6,191,411,441
Last Dividend
9
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of ALBERTDA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-08-03 | August 03, 23 | 9 | 9 | 2023-08-03 | 2023-09-09 | |
| 2022-08-01 | August 01, 22 | 9 | 9 | 2022-08-02 | 2022-09-08 | |
| 2021-09-06 | September 06, 21 | 6 | 6 | 2021-09-07 | 2021-10-14 | |
| 2020-03-13 | March 13, 20 | 7 | 7 | 2020-03-16 | 2020-04-02 | |
| 2019-08-01 | August 01, 19 | 6 | 6 | 2019-08-02 | 2019-09-08 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 360.26 Cr | 128.40 Cr | 231.86 Cr | 0.6436 | 1.95 Cr | 89.14 Cr | 133.45 Cr | 75.42 Cr | 132.15 | 104.54 Cr | 0.2093 |
| 2023-03-31 | 341.56 Cr | 123.09 Cr | 218.48 Cr | 0.6396 | 1.90 Cr | 49.74 Cr | 36.24 Cr | 36.17 Cr | 63.39 | 59.87 Cr | 0.1059 |
| 2022-03-31 | 312.43 Cr | 117.52 Cr | 194.91 Cr | 0.6239 | 1.60 Cr | 35.56 Cr | 31.99 Cr | 35.26 Cr | 61.78 | 56.78 Cr | 0.1129 |
| 2021-03-31 | 246.31 Cr | 88.03 Cr | 158.29 Cr | 0.6426 | 1.53 Cr | 28.94 Cr | 10.92 Cr | 22.14 Cr | 38.80 | 36.46 Cr | 0.0899 |
| 2020-03-31 | 318.43 Cr | 107.99 Cr | 210.44 Cr | 0.6609 | 1.64 Cr | 43.46 Cr | 26.15 Cr | 19.17 Cr | 33.59 | 37.61 Cr | 0.0602 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 5.44 Cr | 497.99 Cr | 115.01 Cr | 382.9810 Cr | 3.32 Cr | -2.11 Cr | 43.61 Cr | 88.28 Cr | 3.24 Cr | 0.00 Cr | 32.84 Cr | 99.0476 Cr |
| 2023-03-31 | 1.45 Cr | 423.39 Cr | 111.83 Cr | 311.5676 Cr | 5.32 Cr | 3.87 Cr | 50.68 Cr | 80.28 Cr | 58.73 Cr | -3.97 Cr | 29.88 Cr | 98.9375 Cr |
| 2022-03-31 | 2.28 Cr | 402.84 Cr | 123.37 Cr | 279.4711 Cr | 5.66 Cr | 3.39 Cr | 39.18 Cr | 84.62 Cr | 70.12 Cr | 0.00 Cr | 55.55 Cr | 108.9432 Cr |
| 2021-03-31 | 5.08 Cr | 341.40 Cr | 97.02 Cr | 244.3820 Cr | 1.62 Cr | -3.46 Cr | 35.75 Cr | 83.24 Cr | 44.63 Cr | 0.00 Cr | 28.86 Cr | 80.6091 Cr |
| 2020-03-31 | 6.42 Cr | 320.22 Cr | 97.42 Cr | 222.7979 Cr | 2.05 Cr | -4.37 Cr | 42.72 Cr | 90.29 Cr | -2.17 Cr | 0.00 Cr | 24.17 Cr | 80.9788 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 45.5022 Cr | -39.1078 Cr | -8.2699 Cr | 34.6282 Cr | 3.9935 Cr | 5.4389 Cr | -10.8740 Cr | 75.4201 Cr | -1.8690 Cr | -5.1691 Cr | 7.0704 Cr |
| 2023-03-31 | 10.5150 Cr | -4.9952 Cr | -6.3622 Cr | 5.2781 Cr | -0.8308 Cr | 1.4454 Cr | -5.2369 Cr | 50.7354 Cr | 0.2032 Cr | -5.1498 Cr | -11.5033 Cr |
| 2022-03-31 | 40.3647 Cr | -39.6973 Cr | -4.8801 Cr | 29.2833 Cr | -4.1323 Cr | -1.4895 Cr | -11.0814 Cr | 47.2976 Cr | -1.1557 Cr | -3.4358 Cr | -3.4311 Cr |
| 2021-03-31 | 36.6107 Cr | -36.6844 Cr | -1.7050 Cr | 34.9786 Cr | -1.7741 Cr | 4.6428 Cr | -1.6321 Cr | 27.4436 Cr | -1.2163 Cr | -0.0402 Cr | 6.9748 Cr |
| 2020-03-31 | 30.0934 Cr | -19.9989 Cr | -10.1699 Cr | 14.6705 Cr | 0.0048 Cr | 6.4169 Cr | -15.4229 Cr | 28.9544 Cr | -0.9192 Cr | -8.8834 Cr | 1.3348 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 83.08 Cr | 26.34 Cr | 56.75 Cr | 0.6830 | -1.03 Cr | -9.39 Cr | -16.45 | -8.34 Cr | -0.1130 |
| 2024-09-30 | 98.44 Cr | 30.32 Cr | 68.12 Cr | 0.6920 | 4.55 Cr | 18.07 Cr | 31.67 | 26.86 Cr | 0.1836 |
| 2024-06-30 | 89.36 Cr | 30.30 Cr | 59.06 Cr | 0.6609 | 30.69 Cr | 18.84 Cr | 33.02 | 23.94 Cr | 0.2109 |
| 2024-03-31 | 89.06 Cr | 54.20 Cr | 34.86 Cr | 0.3914 | 7.74 Cr | 12.91 Cr | 22.63 | 20.01 Cr | 0.1450 |
| 2023-12-31 | 88.28 Cr | 32.80 Cr | 55.48 Cr | 0.6285 | 23.55 Cr | 18.72 Cr | 32.80 | 25.24 Cr | 0.2120 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.70 Cr | 318.59 Cr | 322.29 Cr | 0.00 Cr | 47.48 Cr | 416.15 Cr | 95.32 Cr | 535.33 Cr | 122.10 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 285.23 Cr | 0.00 Cr | 0.00 Cr | 285.23 Cr | 0.00 Cr | 0.00 Cr | -382.98 Cr |
| 2024-03-31 | 31.16 Cr | 254.30 Cr | 285.46 Cr | 29.33 Cr | 43.61 Cr | 371.63 Cr | 88.28 Cr | 497.99 Cr | 115.01 Cr |
| 2023-12-31 | -222.87 Cr | 445.74 Cr | 222.87 Cr | 0.00 Cr | 0.00 Cr | 222.87 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 4.83 Cr | 233.41 Cr | 238.24 Cr | 32.47 Cr | 39.80 Cr | 324.13 Cr | 85.76 Cr | 454.55 Cr | 104.26 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 18.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 12.91 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 18.72 Cr | 3.37 Cr | 0.00 Cr | 0.00 Cr | 3.37 Cr | 20.44 Cr | 17.07 Cr | 0.00 Cr | 3.37 Cr |
| 2023-09-30 | 20.30 Cr | 2.92 Cr | 0.00 Cr | 0.00 Cr | 2.92 Cr | 17.07 Cr | 14.16 Cr | 0.00 Cr | 2.92 Cr |
| 2023-06-30 | 23.49 Cr | 3.71 Cr | 0.00 Cr | 0.00 Cr | 3.71 Cr | 5.42 Cr | 1.71 Cr | 0.00 Cr | 3.71 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹818.00 | ₹97,909,552,940.00 | ₹37,417.00 |
Key Executives
No executive data available.
FAQs about Albert David Limited
The current price is ₹1,084.85.
The range is ₹255.0-1130.0.
The market capitalization is ₹619.14 crores.
The dividend yield is 1.35%.
The P/E ratio is 11.98.
The company operates in the Healthcare sector.
Overview of Albert David Limited (ISIN: INE155C01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹619.14 crores and an average daily volume of 2,888 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹9.